Citadel Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$217M Sell
615,500
-150,100
-20% -$53.5M 0.04% 427
2025
Q4
$251M Sell
765,600
-192,300
-20% -$61M 0.04% 403
2025
Q3
$270M Buy
957,900
+2,700
+0.3% +$783K 0.04% 361
2025
Q2
$267M Buy
955,200
+45,500
+5% +$12.9M 0.05% 313
2025
Q1
$283M Sell
909,700
-305,100
-25% -$90.1M 0.05% 265
2024
Q4
$317M Buy
1,214,800
+160,000
+15% +$47.5M 0.05% 251
2024
Q3
$340M Sell
1,054,800
-165,500
-14% -$54.1M 0.07% 211
2024
Q2
$381M Sell
1,220,300
-534,700
-30% -$157M 0.08% 175
2024
Q1
$499M Buy
1,755,000
+657,500
+60% +$192M 0.1% 129
2023
Q4
$316M Sell
1,097,500
-19,500
-2% -$5.31M 0.06% 204
2023
Q3
$300M Buy
1,117,000
+207,000
+23% +$51.7M 0.06% 197
2023
Q2
$202M Buy
910,000
+60,200
+7% +$14M 0.04% 317
2023
Q1
$205M Sell
849,800
-185,400
-18% -$45.5M 0.05% 315
2022
Q4
$272M Sell
1,035,200
-114,900
-10% -$30.8M 0.06% 232
2022
Q3
$259M Sell
1,150,100
-386,800
-25% -$93.8M 0.06% 226
2022
Q2
$374M Buy
1,536,900
+462,000
+43% +$113M 0.1% 129
2022
Q1
$260M Buy
1,074,900
+532,400
+98% +$122M 0.05% 248
2021
Q4
$122M Sell
542,500
-331,200
-38% -$69.9M 0.02% 554
2021
Q3
$186M Buy
873,700
+293,900
+51% +$67.6M 0.04% 375
2021
Q2
$141M Buy
579,800
+52,200
+10% +$12.8M 0.03% 494
2021
Q1
$131M Sell
527,600
-73,900
-12% -$17.6M 0.03% 461
2020
Q4
$138M Buy
601,500
+66,000
+12% +$15.2M 0.04% 398
2020
Q3
$136M Sell
535,500
-123,500
-19% -$30.6M 0.04% 317
2020
Q2
$155M Sell
659,000
-127,000
-16% -$29M 0.06% 245
2020
Q1
$159M Sell
786,000
-317,300
-29% -$69.3M 0.07% 190
2019
Q4
$266M Buy
1,103,300
+43,100
+4% +$9.5M 0.12% 118
2019
Q3
$205M Buy
1,060,200
+274,000
+35% +$52.6M 0.1% 152
2019
Q2
$145M Sell
786,200
-285,400
-27% -$51.1M 0.07% 257
2019
Q1
$204M Buy
1,071,600
+279,500
+35% +$53.4M 0.1% 143
2018
Q4
$154M Buy
792,100
+314,700
+66% +$61.4M 0.08% 181
2018
Q3
$99M Buy
477,400
+56,700
+13% +$11.2M 0.04% 422
2018
Q2
$77.7M Sell
420,700
-250,000
-37% -$44.2M 0.04% 471
2018
Q1
$114M Buy
670,700
+4,500
+0.7% +$826K 0.06% 277
2017
Q4
$116M Buy
666,200
+265,300
+66% +$47M 0.07% 282
2017
Q3
$74.7M Sell
400,900
-81,500
-17% -$14.4M 0.06% 352
2017
Q2
$83.1M Sell
482,400
-108,800
-18% -$17.7M 0.07% 284
2017
Q1
$97M Sell
591,200
-400
-0.1% -$66.5K 0.09% 211
2016
Q4
$86.5M Sell
591,600
-49,000
-8% -$7.37M 0.09% 205
2016
Q3
$107M Buy
640,600
+198,900
+45% +$33.6M 0.11% 153
2016
Q2
$67.2M Buy
441,700
+59,200
+15% +$9.2M 0.07% 235
2016
Q1
$57.3M Buy
382,500
+153,100
+67% +$22.7M 0.07% 251
2015
Q4
$37.2M Sell
229,400
-75,300
-25% -$11.8M 0.04% 526
2015
Q3
$42.1M Buy
304,700
+9,400
+3% +$1.48M 0.04% 511
2015
Q2
$45.3M Buy
295,300
+71,600
+32% +$11.5M 0.04% 552
2015
Q1
$35.8M Sell
223,700
-91,100
-29% -$14.3M 0.03% 644
2014
Q4
$50.1M Sell
314,800
-300
-0.1% -$46.7K 0.05% 474
2014
Q3
$44.3M Buy
315,100
+100,200
+47% +$13.1M 0.05% 478
2014
Q2
$25.4M Sell
214,900
-95,500
-31% -$11.1M 0.03% 682
2014
Q1
$38.3M Sell
310,400
-71,900
-19% -$8.72M 0.04% 505
2013
Q4
$43.6M Sell
382,300
-36,100
-9% -$4.11M 0.06% 415
2013
Q3
$46.8M Buy
418,400
+110,200
+36% +$11.9M 0.07% 344
2013
Q2
$30.4M Buy
+308,200
New +$32M 0.05% 444

Other funds holding AMGN

Citadel Advisors's AMGN Position: Q1 2026 in Review

Citadel Advisors increased its Amgen (AMGN) stake by 54% in Q1 2026, buying an estimated $23.2M and bringing the position to 184,963 shares worth $65.1M. The position accounts for 0.01% of the portfolio, ranked #1127.

Citadel Advisors first reported a position in AMGN in Q2 2013 and has held it in 51 quarters since. The position peaked at $230M in Q2 2020. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Citadel Advisors held 184,963 shares of Amgen worth $65.1M as of Q1 2026.
  • Citadel Advisors bought 64,983 Amgen shares in Q1 2026, an estimated $23.2M.
  • Amgen made up 0.01% of Citadel Advisors's portfolio in Q1 2026, its #1127 holding.
  • Citadel Advisors first reported a position in Amgen in Q2 2013 and has held it in 51 quarters since.
  • Citadel Advisors's Amgen position peaked at $230M in Q2 2020.
  • 3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.